At ORA, we are developing innovative radiochemistry platforms
Personalized medicine is a young but rapidly advancing field of healthcare. In order for personalized medicine to deploy effectively, various PET diagnostic tracers must be made available to healthcare providers and their patients. Therefore the combined challenges of researchers, developers and producers is to provide these tracers efficiently and in a competitive way to the market place.
Since its inception, the NEPTIS concept aimed to address in full these different challenges by nature: restoring freedom for researchers with an open and flexible platform, providing developers with a robust tool from clinical trials to commercial production, and offering producers a guarantee of reliable and repetitive performance.
At ORA, we aim at providing optimized radiochemical applications and to become a recognized world player in providing the best possible integrated chemistry experience meeting the regulatory and operational needs of todayâ€™s and tomorrowâ€™s PET pharmaceutical producers and developers.
At ORA, we are developing, designing, manufacturing and supplying multi-purpose radiochemistry synthesizers, based on an open platform for the production of todayâ€™s and tomorrowâ€™s radiopharmaceuticals that deliver outstanding customer experience and production performance.
At ORA, we do believe that our operating environment is a Â«Â radiopharmacy ecosystemÂ Â», that production experience provide the major guidelines for our development and that customer feedback is the key indicator of the quality of our products.
Our Company Quality Policy
ORA will consistently provide products and services that meet or exceed the requirements and expectations of our customers. We will actively pursue ever improving quality through programs that enable each employee to do their job right the first time and every time.
ORA will consistently provide a quality management system in line with ISO 13485 requirements and with the MHLW Ministerial Ordinance NÂ°169 (Japanese regulatory requirements).